Basics Relay Therapeutics, Inc. IPO Date: July 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.21B Activated in VL: True Average Daily Range Avg Daily Range: $0.64 | 3.37% Avg Daily Range (30 D): $0.22 | 3.91% Avg Daily Range (90 D): $0.13 | 3.06% Institutional Daily Volume Avg Daily Volume: .96M Avg Daily Volume (30 D): 1.43M Avg Daily Volume (90 D): 1.55M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 114 Avg Trade Size (Sh.) (90 D): 137 Institutional Trades Total Inst.Trades: 2,408 Avg Inst. Trade: $2.24M Avg Inst. Trade (30 D): $1.34M Avg Inst. Trade (90 D): $1.25M Avg Inst. Trade Volume: .15M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.81M Avg Closing Trade (30 D): $1.45M Avg Closing Trade (90 D): $1.2M Avg Closing Volume: 195.99K     News Sep 3, 2025 @ 11:00 AM Kymera Therapeutics Appoints Brian Adams as Chief ... Source: Brian Adams May 27, 2025 @ 1:45 PM Healthcare's Quiet AI Boom Is Creating a New Class... Source: Prnewswire Dec 11, 2024 @ 11:00 AM Relay Therapeutics Announces Updated Interim Data ... Source: N/A Sep 11, 2024 @ 10:46 PM Why Relay Therapeutics Plummeted by Nearly 14% Tod... Source: Eric Volkman Sep 11, 2024 @ 12:21 AM Relay Therapeutics Announces Pricing of Public Off... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.92 $-.41 $-.46 Diluted EPS $-1.92 $-.41 $-.46 Revenue $ 8.36M $ .68M $ 7.68M Gross Profit $ $ $ Net Income / Loss $ -311.55M $ -70.38M $ -77.07M Operating Income / Loss $ -343.06M $ -76.85M $ -84.87M Cost of Revenue $ $ $ Net Cash Flow $ -20.63M $ -10.21M $ M PE Ratio